SCHEMBL2719862

SCHEMBL2719862

Fc1ccc2n[c]c(-c3ccccn3)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBFB Q13951 2/20 0.49
METAP1 P53582 2/20 0.49
METAP2 P50579 1/20 0.49
GRM5 P41594 5/20 0.43
KDM4E B2RXH2 4/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC2A1 P11166 1/20 0.40
FFAR1 O14842 3/20 0.39
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
NPY5R Q15761 1/20 0.38
NPC1 O15118 1/20 0.37
CCR1 P32246 2/20 0.37
CCR5 P51681 2/20 0.37
CCR8 P51685 2/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
BLM P54132 1/20 0.37
HIF1A Q16665 1/20 0.37
DOHH Q9BU89 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320187 0.83 KDM4E (0.47) METAP1METAP2KDM4ETDP1LMNA
SCHEMBL10462546 0.77 BACE1 (0.42) KDM4ELMNAL3MBTL1NPC1CYP1A2
SCHEMBL15831591 0.72 METAP1 (0.54) CBFBMETAP1METAP2GRM5KDM4E
SCHEMBL22238047 0.71 METAP2 (0.49) CBFBMETAP1METAP2GRM5KDM4E
SCHEMBL15229223 0.69 ALDH1A1 (0.43) KDM4ENPC1POLBTP53HSP90AA1
SCHEMBL1780817 0.68 KDM4E (0.45) CBFBMETAP1METAP2GRM5KDM4E
SCHEMBL7549266 0.68 CCR1 (0.64) CBFBMETAP1METAP2GRM5KDM4E
SCHEMBL20067937 0.68 PIK3CD (0.58) CBFBMETAP1METAP2GRM5KDM4E
SCHEMBL4757272 0.67 KDM4E (0.40) KDM4ECYP1A2
SCHEMBL11160532 0.67 PDGFRB (0.38) GRM5NPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445900-A2 POLYCYCLIC DERIVATIVES OF PYRIDINE AND THEIR USE IN THE TREATMENT OF (INTER ALIA) RHEUMATOID ARTHRITIS AND SIMILAR DISEASES Amgen, Inc (US) 2012-05-02 EP disclosed
WO-2010151740-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2010-12-29 WO disclosed